L-carnitine supplements at 0.254 g/day for 252 weeks reduced fasting blood glucose, insulin resistance, and HbA1c but NOT serum insulin levels [3][41]
Putting the evidence side by side Here is the blunt comparison: AOD 9604: 2.6 kg weight loss in 12 weeks (best result), failed six clinical trials, development terminated Semaglutide: 15 to 17 percent body weight loss over 68 weeks, FDA approved, thousands of study participants, consistent results across multiple trials There is no way to frame this comparison that puts AOD 9604 on equal footing with semaglutide when it comes to clinical evidence
About this article Cite this article Al-Hakeim, H.K., Al-Rubaye, H.T., Al-Hadrawi, D.S
PMID: 279 DelbonoORodriguesACZBonillaHJMessiML
Higher-risk situations may include: Older age Existing sarcopenia or frailty Recent falls Difficulty rising from a chair Low baseline physical activity Very low protein or calorie intake Rapid or excessive appetite suppression Chronic kidney, liver, pulmonary, or cardiovascular disease Cancer or another catabolic illness Recent hospitalization Significant gastrointestinal adverse effects Very rapid weight loss Inability to participate in resistance exercise These factors do not automatically make GLP-1 therapy inappropriate
Why Some People Experience Severe Nausea and Others Dont Like any medicine, people will have different reactions
